Works matching IS 08876924 AND DT 2007 AND VI 21 AND IP 3

Results: 39
    1
    2
    3
    4
    5

    Antitumor activity of sorafenib in FLT3-driven leukemic cells.

    Published in:
    Leukemia (08876924), 2007, v. 21, n. 3, p. 439, doi. 10.1038/sj.leu.2404508
    By:
    • Auclair, D.;
    • Miller, D.;
    • Yatsula, V.;
    • Pickett, W.;
    • Carter, C.;
    • Chang, Y.;
    • Zhang, X.;
    • Wilkie, D.;
    • Burd, A.;
    • Shi, H.;
    • Rocks, S.;
    • Gedrich, R.;
    • Abriola, L.;
    • Vasavada, H.;
    • Lynch, M.;
    • Dumas, J.;
    • Trail, P. A.;
    • Wilhelm, S. M.
    Publication type:
    Article
    6

    Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.

    Published in:
    Leukemia (08876924), 2007, v. 21, n. 3, p. 446, doi. 10.1038/sj.leu.2404501
    By:
    • Esteve, J.;
    • Escoda, L.;
    • Martín, G.;
    • Rubio, V.;
    • Díaz-Mediavilla, J.;
    • González, M.;
    • Rivas, C.;
    • Álvarez, C.;
    • González San Miguel, J. D.;
    • Brunet, S.;
    • Tomás, J. F.;
    • Tormo, M.;
    • Sayas, M. J.;
    • Sánchez Godoy, P.;
    • Colomer, D.;
    • Bolufer, P.;
    • Sanz, M. A.
    Publication type:
    Article
    7
    8
    9

    Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.

    Published in:
    Leukemia (08876924), 2007, v. 21, n. 3, p. 541, doi. 10.1038/sj.leu.2404520
    By:
    • Gutiérrez, N. C.;
    • Ocio, E. M.;
    • de las Rivas, J.;
    • Maiso, P.;
    • Delgado, M.;
    • Fermiñ&;#x00E1;n, E.;
    • Arcos, M. J.;
    • Sánchez, M. L.;
    • Hernández, J. M.;
    • San Miguel, J. F.
    Publication type:
    Article
    10

    Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.

    Published in:
    Leukemia (08876924), 2007, v. 21, n. 3, p. 453, doi. 10.1038/sj.leu.2404521
    By:
    • Thomas, X.;
    • Raffoux, E.;
    • Botton, S. de;
    • Pautas, C.;
    • Arnaud, P.;
    • de Revel, T.;
    • Reman, O.;
    • Terré, C.;
    • Corront, B.;
    • Gardin, C.;
    • Le, Q.-H.;
    • Quesnel, B.;
    • Cordonnier, C.;
    • Bourhis, J.-H.;
    • Elhamri, M.;
    • Fenaux, P.;
    • Preudhomme, C.;
    • Michallet, M.;
    • Castaigne, S.;
    • Dombret, H.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Clinical significance of TP53 mutation in myeloma.

    Published in:
    Leukemia (08876924), 2007, v. 21, n. 3, p. 582, doi. 10.1038/sj.leu.2404524
    By:
    • Chng, W. J.;
    • Price-Troska, T.;
    • Gonzalez-Paz, N.;
    • Van Wier, S.;
    • Jacobus, S.;
    • Blood, E.;
    • Henderson, K.;
    • Oken, M.;
    • Van Ness, B.;
    • Greipp, P.;
    • Rajkumar, S. V.;
    • Fonseca, R.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26

    Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.

    Published in:
    Leukemia (08876924), 2007, v. 21, n. 3, p. 556, doi. 10.1038/sj.leu.2404537
    By:
    • Yoshimi, A.;
    • Mohamed, M.;
    • Bierings, M.;
    • Urban, C.;
    • Korthof, E.;
    • Zecca, M.;
    • Sykora, K.-W.;
    • Duffner, U.;
    • Trebo, M.;
    • Matthes-Martin, S.;
    • Sedlacek, P.;
    • Klingebiel, T.;
    • Lang, P.;
    • Führer, M.;
    • Claviez, A.;
    • Wössmann, W.;
    • Pession, A.;
    • Arvidson, J.;
    • O'Marcaigh, A. S.;
    • van den Heuvel-Eibrink, M. M.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39